Dr Urvish Pandya is the Director of Allotrope Scientific Ltd and a highly experienced consultant in chemical development, process chemistry and manufacturing. With over 30 years of industrial and consultancy experience, he supports organisations across the chemical, pharmaceutical and materials sectors in translating laboratory science into robust, scalable manufacturing processes.
His expertise spans route design and selection, process development, impurity control, crystallisation, and scale up from grams to commercial manufacture. He has extensive experience in supporting early phase development through to GMP manufacturing, including CMC strategy, regulatory submissions and management of external CRO and CDMO partners.
A key strength of his work lies in investigation and problem solving, particularly in understanding and resolving complex process challenges. He applies a strong foundation in chemical fundamentals alongside practical engineering and operational insight to diagnose issues, develop robust solutions and build process understanding. This includes identifying critical process parameters, improving robustness and ensuring reliable scale up.
Dr Pandya has worked across a wide range of sectors including pharmaceuticals, fine chemicals, advanced materials and sustainable processes. His work includes the development of continuous processing technologies, integration of circular and green chemistry principles, and troubleshooting of complex manufacturing and scale up issues.
In addition to his technical expertise, he brings strong experience in project leadership, technology transfer and innovation programmes. He has monitored over 40 Innovate UK funded projects across health, materials and manufacturing, providing independent oversight on technical delivery, risk and value for public funding.
His approach combines deep chemical understanding with practical engineering, regulatory and commercial awareness, enabling clients to design processes with the end in mind and deliver scalable, reliable and compliant solutions.
Dr Urvish Pandya is the Director of Allotrope Scientific Ltd. Since founding the company in 2021, he has supported organisations across the chemical, pharmaceutical and materials sectors in the UK, EU, US, Middle East and India, translating complex chemistry into robust, scalable processes from early development through to GMP manufacture and commercial supply.
His recent work includes supporting programmes from early phase development to clinical progression, including oncology and advanced therapeutic platforms, alongside advisory work on process validation, analytical strategy and regulatory CMC content. He has been actively involved in troubleshooting scale up challenges, resolving process and analytical issues, and building process understanding to enable reliable manufacturing.
In parallel, he has contributed to the development of innovative technologies in areas such as continuous processing, polymorphism control and sustainable chemical processes, and has monitored over 40 Innovate UK funded projects across health, materials and manufacturing, providing independent oversight on technical delivery, risk and value.
His approach combines strong chemical fundamentals with practical engineering, regulatory and operational insight, enabling effective problem solving and delivery of scalable, compliant and commercially viable solutions.
He focuses on designing processes with the end in mind, ensuring reliable scale up and avoiding costly surprises in manufacturing.
Prior to founding Allotrope Scientific Ltd in 2021, Dr Urvish Pandya developed a broad international career across industry and academia in India, USA, France and the UK. His experience spans chemical development from early route definition and investigation through to process design, scale up and manufacturing.
He has worked across early phase development, including route scouting and initial scale up, through to the development and transfer of robust processes for GMP manufacture and commercial supply. His experience includes building and leading development capabilities, establishing and scaling processes from laboratory to pilot and commercial scale, and supporting the delivery of complex programmes within regulated environments.
He has contributed to the development of innovative process technologies, including continuous processing and sustainable chemical routes, and has extensive experience in troubleshooting, impurity control and process optimisation. His work has involved close collaboration with multidisciplinary teams across chemistry, engineering, analytical, quality and operations to deliver practical and reliable manufacturing solutions.
Strategic to hands-on support across chemical development, scale up and manufacturing
Process chemistry and chemical development, including route scouting, synthetic organic chemistry and development of efficient, scalable processes.
Process development, scale up and validation, including application of Quality by Design to deliver robust and reliable manufacturing processes.
Investigation and problem solving, including troubleshooting of complex process, analytical and scale up challenges and development of process understanding.
Technology transfer and manufacturing support, including transfer from laboratory to pilot and commercial scale and support for GMP manufacture.
External partner management, including sourcing, qualification and oversight of raw material suppliers, CRO, CDMO and CMO partners.
Drug substance development and CMC support, including quality, technical and regulatory aspects aligned to phase appropriate requirements.
Innovation and process improvement, including continuous processing, sustainable chemistry and development of new process technologies.
Project leadership and interim management, supporting delivery of multidisciplinary programmes across development and manufacturing.
Intellectual property support and expert witness activities.
